A Review on Recent Selective Laser Sintering Printing of Medicines

EasyChair Preprint 5327

Abstract

Rapid Prototyping (RP) is a series of technologies for rapidly manufacturing a computer part or assembly. Computer-Aided Design (CAD) makes it possible to quickly create an intricate 3D component design. It uses a computer-aided design model that allows human interference to be reduced to an absolute minimum. It is capable of visualizing complex models as well as the way to test product efficiency. In addition, it can be used for consumer-preference research.

SLS has a number of advantages that set it apart in the pharmaceutical industry. SLS' ability to create free-form 3D structures without the use of external support materials, opens up possibilities for the fabrication of a wide range of dosage types. SLS also allows the formation of objects with high porosity and pore connectivity levels. Unlike other printing technologies (such as fused deposition modeling (FDM) and stereolithography (SLA), SLS does not necessitate pre-processing of the starting material or the addition of additional excipients that may be harmful. The lack of solvents in the process improves the protection and stability of drug compounds that are susceptible to hydrolysis. As compared to other 3D printing technologies (e.g. FDM and SLA) and traditional manufacturing methods (e.g. injection molding), previous studies have shown that SLS is more cost-efficient for the production of custom parts.

Keyphrases: Pharmaceutical, Rapid Prototyping, Selective Laser Sintering (SLS), medicine materials

@booklet{EasyChair:5327,
  author    = {Amirhossein Ahmadian},
  title     = {A Review on Recent Selective Laser Sintering Printing of Medicines},
  howpublished = {EasyChair Preprint 5327},
  year      = {EasyChair, 2021}}